Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.4761
-0.0020 (-0.42%)
At close: Jun 3, 2025, 4:00 PM
0.4930
+0.0169 (3.55%)
After-hours: Jun 3, 2025, 6:20 PM EDT
Talphera Revenue
Talphera had revenue of $27.00K in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $27.00K, down -95.85% year-over-year.
Revenue (ttm)
$27.00K
Revenue Growth
-95.85%
P/S Ratio
361.54
Revenue / Employee
$2,077
Employees
13
Market Cap
9.76M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
TLPH News
- 20 days ago - Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 27 days ago - Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025 - PRNewsWire
- 2 months ago - Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million - PRNewsWire
- 2 months ago - Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025 - PRNewsWire
- 5 months ago - Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - PRNewsWire